文献速递腹部MR

磁共振扩散加权成像诊断自身免疫性肝病肝纤维化程度

Diagnosis of liver fibrosis degree in autoimmune liver disease by magnetic resonance diffusion-weighted imaging.
PubMed 文献 · Abdom Radiol (NY) · 2025-11-08

这项回顾性研究分析了157例自身免疫性肝病患者,以肝活检为金标准,评估DWI的ADC值对肝纤维化分期、肝损伤和炎症的诊断价值。ADC值随纤维化分期和炎症分级升高而逐渐降低,S4期ADC值显著低于S0期(AUC=0.91)。ADC值与血清IL-17、TNF-α、ALT、AST均呈显著负相关,不同纤维化分期有相应最佳ADC截断值。

要点

  • ADC值随纤维化分期(S0–S4)和炎症分级(G0–G4)升高而逐渐降低。
  • 区分≥S1、≥S2、≥S3、S4的最佳ADC截断值分别为1.47、1.35、1.24、1.12×10-³ mm²/s。
  • ADC与ALT、AST、IL-17、TNF-α均呈显著负相关(r=-0.39至-0.49,p<0.001)。

核心结论

  • DWI的ADC值可作为评估自身免疫性肝病患者肝纤维化和炎症的可靠无创生物标志物。

研究设计与样本

  • 回顾性研究,纳入157例自身免疫性肝病患者,以肝活检作为纤维化分期的金标准,采用DWI测量ADC值并与纤维化分期(S0–S4)和炎症分级(G0–G4)比较。

关键影像表现/征象

  • ADC值随纤维化分期增加和炎症分级升高而逐渐降低。
  • S4期ADC值显著低于S0期,AUC为0.91。

诊断标准与关键数值

  • ADC区分≥S1的最佳截断值为1.47×10-³ mm²/s(AUC=0.90)。
  • ADC区分≥S2的最佳截断值为1.35×10-³ mm²/s(AUC=0.88)。
  • ADC区分≥S3的最佳截断值为1.24×10-³ mm²/s(AUC=0.90)。
  • ADC区分S4的最佳截断值为1.12×10-³ mm²/s(AUC=0.91)。

临床应用与阅片要点

  • ADC值可作为无创评估自身免疫性肝病肝纤维化分期和炎症的参考指标。
  • 解读ADC值时需结合纤维化分期和炎症分级,ADC值随二者升高而逐渐降低。
  • ADC值与ALT、AST、IL-17、TNF-α呈负相关,提示其与肝损伤和炎症相关。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

BACKGROUND: Fibrosis is a key pathological feature of autoimmune liver diseases (AILD). This study evaluates the diagnostic potential of apparent diffusion coefficient (ADC) values from diffusion-weighted imaging (DWI) for liver fibrosis staging, liver damage, and inflammation in AILD patients.

METHODS: This retrospective study analyzed the diagnostic performance of ADC values from DWI in 157 AILD patients. Liver biopsy served as the gold standard for fibrosis staging. The relationship between ADC values and liver function markers (AST, ALT) and inflammatory cytokines (IL-17, TNF-α) was assessed. To evaluate diagnostic accuracy, ADC values were compared across different fibrosis stages (S0 to S4) and inflammation grades (G0 to G4).

RESULTS: ADC values decreased progressively with increasing fibrosis stages and inflammation grades. Notably, ADC values were significantly lower in S4 compared to S0, with an AUC of 0.91. Pearson correlation analysis revealed significant negative correlations between ADC and serum IL-17 (r = -0.39, p < 0.001), TNF-α (r = -0.43, p < 0.001), as well as liver function markers, ALT (r = -0.49, p < 0.001) and AST (r = -0.46, p < 0.001). ROC analysis showed optimal ADC cut-off values for distinguishing fibrosis stages: 1.47 × 10-³ mm²/s for ≥ S1 (AUC = 0.90), 1.35 × 10-³ mm²/s for ≥ S2 (AUC = 0.88), 1.24 × 10-³ mm²/s for ≥ S3 (AUC = 0.90), and 1.12 × 10-³ mm²/s for S4 (AUC = 0.91).

CONCLUSION: This study highlights ADC values from DWI as a reliable non-invasive biomarker for assessing liver fibrosis and inflammation in AILD patients.

来源:Abdom Radiol (NY),查看原文。版权归原作者所有。

引用

  1. Lu Y, Chen J, Dong J, et al. Diagnosis of liver fibrosis degree in autoimmune liver disease by magnetic resonance diffusion-weighted imaging. Abdom Radiol (NY). 2025. PMID: 41204952. doi:10.1007/s00261-025-05234-x

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。